First Horizon Advisors, Inc. Beam Therapeutics Inc. Transaction History
First Horizon Advisors, Inc.
- $3.81 Billion
- Q2 2025
A detailed history of First Horizon Advisors, Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 685 shares of BEAM stock, worth $12,234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
685
Previous 1,023
33.04%
Holding current value
$12,234
Previous $19,000
42.11%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BEAM
# of Institutions
247Shares Held
94.9MCall Options Held
425KPut Options Held
309K-
Farallon Capital Management LLC San Francisco, CA9.93MShares$177 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.87MShares$158 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$158 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$136 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$84.5 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.26B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...